Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Mar 23:14:46.
doi: 10.1186/s12916-016-0598-2.

Clinical use of whole genome sequencing for Mycobacterium tuberculosis

Adam A Witney  1 , Catherine A Cosgrove  2   3 , Amber Arnold  3 , Jason Hinds  2 , Neil G Stoker  2 , Philip D Butcher  2
Affiliations
Review

Clinical use of whole genome sequencing for Mycobacterium tuberculosis

Adam A Witney et al. BMC Med. .

Abstract

Drug-resistant tuberculosis (TB) remains a major challenge to global health and to healthcare in the UK. In 2014, a total of 6,520 cases of TB were recorded in England, of which 1.4 % were multidrug-resistant TB (MDR-TB). Extensively drug-resistant TB (XDR-TB) occurs at a much lower rate, but the impact on the patient and hospital is severe. Current diagnostic methods such as drug susceptibility testing and targeted molecular tests are slow to return or examine only a limited number of target regions, respectively. Faster, more comprehensive diagnostics will enable earlier use of the most appropriate drug regimen, thus improving patient outcomes and reducing overall healthcare costs. Whole genome sequencing (WGS) has been shown to provide a rapid and comprehensive view of the genotype of the organism, and thus enable reliable prediction of the drug susceptibility phenotype within a clinically relevant timeframe. In addition, it provides the highest resolution when investigating transmission events in possible outbreak scenarios. However, robust software and database tools need to be developed for the full potential to be realized in this specialized area of medicine.

Keywords: Multidrug resistance; Tuberculosis; Whole genome sequencing.

PubMed Disclaimer

References

    1. Loman NJ, Pallen MJ. XDR-TB genome sequencing: a glimpse of the microbiology of the future. Future Microbiol. 2008;3(2):111–3. doi: 10.2217/17460913.3.2.111. - DOI - PubMed
    1. Public Health England . Tuberculosis in the UK: 2015 report (presenting data to end of 2014) London: Public Health England; 2015.
    1. Thorpe TC, Wilson ML, Turner JE, DiGuiseppi JL, Willert M, Mirrett S, et al. BacT/Alert: an automated colorimetric microbial detection system. J Clin Microbiol. 1990;28(7):1608–12. - PMC - PubMed
    1. World Health Organization (WHO). Guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update. Geneva: WHO; 2011. Available from: http://www.ncbi.nlm.nih.gov/books/NBK148644. - PubMed
    1. Lange C, Abubakar I, Alffenaar JW, Bothamley G, Caminero JA, Carvalho ACC, et al. Management of patients with multidrug-resistant/extensively drug-resistant tuberculosis in Europe: a TBNET consensus statement. Eur Respir J. 2014;44(1):23–63. doi: 10.1183/09031936.00188313. - DOI - PMC - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources